0:00
11:00
@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.
Altri episodi di "Healthspan"
Non perdere nemmeno un episodio di “Healthspan”. Iscriviti all'app gratuita GetPodcast.